Short answer
Oscar Health, Inc. (OSCR) filed its Q2 2026 10-Q quarterly report on Aug 7, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $6M (down 6.2% year over year) with net income of $362M.
Q2 2026 key financials · XBRL
- Revenue
- $6M
- −6.2% YoY · +6.6% QoQ
- Net income
- $362M
- +258.4% YoY · −46.7% QoQ
- Operating margin
- 6376.3%
- EPS (diluted)
- $1.09
- +245.3% YoY · −47.3% QoQ
Source: XBRL data from the Oscar Health, Inc. (OSCR) Q2 2026 10-Q on SEC EDGAR. USD.
Oscar Health, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Total revenue $4.880B, up from $2.864B YoY
- Earnings from operations $388.6M vs loss of $230.5M YoY
- MLR 79.2% vs 91.1%; SG&A ratio 14.2% vs 18.7%
- Membership 2.963M, up 46% YoY; premium revenue $4.789B, up 71%
- Approximately 250–300 thousand members expected retroactively disenrolled; ACA subsidy expiration and regulatory changes threaten enrollment
Risk Factors
- No material changes to 2025 Form 10-K risk factors disclosed
- Executive stock issuance: CEO purchased 1,000,000 Class A shares for $11.9 million
- Insider trading compliance: director’s Rule 10b5-1 plan covers up to 25,000 shares through April 15, 2027
- Executive compensation governance: amended employment agreement with Mario Schlosser dated May 29, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Oscar Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.